MedTech Dive May 21, 2024
J.P. Morgan and RBC analysts are expecting updates on several key markets on Medtronic’s Q4 call, including surgical robotics and pulsed field ablation.
Dive Brief:
- Medtronic’s earnings call on Thursday will close out the season for top medtechs and show if the company can match the earlier successes of its rivals for the cardiovascular, neuromodulation and spine markets.
- Wall Street analysts expect Medtronic to extend its run of mid-single-digit growth quarters, reflecting the positive volume trends in its end markets and positive financials from some of its rivals that have already reported.
- The fourth-quarter results will show whether Medtronic expects to maintain that growth rate in its 2025 fiscal year and shed light on the progress of its pulsed...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices